Rihab Melliti, Medical Oncologist at Hôpital Aix-Pertuis, shared a post on LinkedIn:
“I’m very happy to have attended the Advanced Course from ESMO – European Society for Medical Oncology on Precision Medicine for patients with advanced HR+/HER2− breast cancer in the beautiful city of Zurich.
This course was a great opportunity to deepen my understanding of the latest therapeutic strategies, biomarkers, and personalized treatment approaches in this rapidly evolving field. It also provided valuable insights into how we can better integrate precision oncology into clinical practice to improve patient care.
I also had the privilege of meeting colleagues from different countries and exchanging perspectives on equity and access to treatment – an essential discussion to ensure that advances in oncology benefit all patients. Dafina Ademi Islami, Lamija Sikalo.
Grateful for the inspiring speakers, enriching discussions, and the opportunity to connect with such a dedicated international community.”
Other articles featuring Rihab Melliti on OncoDaily.
